Lotte Ask Reitzel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lotte Ask Reitzel has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Kristian Linnet
Section of Forensic Chemistry, Department of Forensic Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Frederik V’s vej 11, DK-2100 Copenhagen, Denmark
3 shared publications Irene Breum Müller
Section of Forensic Chemistry, Department of Forensic Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Frederik V’s Vej 11, 3, DK-2100, Copenhagen, Denmark
2 shared publications- Kristine Rømer Thomsen
Aarhus University
2 shared publications - Petur Weihe Dalsgaard
Section of Forensic Chemistry, Department of Forensic Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark
2 shared publications - Amir Englund
Institute of Psychiatry, Psychology and Neuroscience, King's College London, England, UK
1 shared publication - Anders Just Pedersen
Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Denmark
1 shared publication
Latest Publications
- Open Access
- 4 May 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e124
Changes in cannabis potency and cannabis-related psychiatric harms: a 23-year ecological study in Denmark
Background: In recent decades, the potency of cannabis resin increased globally, raising concerns, as higher potency has been associated with increased risk of psychiatric harms at the individual level. The aim here was to examine whether changes over time in the potency of seized cannabis resin samples were associated with psychiatric harms at the population level. Methods: Data on ∆-9-tetrahydrocannabinol (THC) concentration in seized cannabis resin were obtained from forensic departments in Denmark (2000–2022), the country reporting the highest potency in Europe. Data on admissions to cannabis treatment, incidence of cannabis-induced psychosis, and dual diagnosis (schizophrenia and cannabis use disorder) were obtained from national registers. Time-dependent associations between potency and the outcomes were examined with mixed-effects linear regression models and associations across age and sex were explored. Candidate time lags were 0–10 years. Results: THC concentration increased almost fourfold: mean 8.3–31.2% from 2000 to 2022. In fully adjusted models, THC was positively associated with first-time cannabis treatment entry at lags of 0–6, strongest at year 0 ( p < 0.0001); incidence of cannabis-induced psychosis at lags of 0–4, strongest at year 0 ( p < 0.0001); and incidence of dual diagnosis at lags of 0–1, strongest at year 0 ( p < 0.01). No positive associations were found in unadjusted models. Subgroup analyses indicated associations in older patients and women. Conclusions: Potency of seized cannabis resin increased almost fourfold from 2000 to 2022. Changes in cannabis potency were positively associated with psychiatric harms at the population level across all outcomes.
- 4 May 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e124
Open AccessChanges in cannabis potency and cannabis-related psychiatric harms: a 23-year ecological study in Denmark
Background: In recent decades, the potency of cannabis resin increased globally, raising concerns, as higher potency has been associated with increased risk of psychiatric harms at the individual level. The aim here was to examine whether changes over time in the potency of seized cannabis resin samples were associated with psychiatric harms at the population level. Methods: Data on ∆-9-tetrahydrocannabinol (THC) concentration in seized cannabis resin were obtained from forensic departments in Denmark (2000–2022), the country reporting the highest potency in Europe. Data on admissions to cannabis treatment, incidence of cannabis-induced psychosis, and dual diagnosis (schizophrenia and cannabis use disorder) were obtained from national registers. Time-dependent associations between potency and the outcomes were examined with mixed-effects linear regression models and associations across age and sex were explored. Candidate time lags were 0–10 years. Results: THC concentration increased almost fourfold: mean 8.3–31.2% from 2000 to 2022. In fully adjusted models, THC was positively associated with first-time cannabis treatment entry at lags of 0–6, strongest at year 0 ( p < 0.0001); incidence of cannabis-induced psychosis at lags of 0–4, strongest at year 0 ( p < 0.0001); and incidence of dual diagnosis at lags of 0–1, strongest at year 0 ( p < 0.01). No positive associations were found in unadjusted models. Subgroup analyses indicated associations in older patients and women. Conclusions: Potency of seized cannabis resin increased almost fourfold from 2000 to 2022. Changes in cannabis potency were positively associated with psychiatric harms at the population level across all outcomes.
- Open Access
- 1 December 2021
- Published by Elsevier in Forensic Science International
- Vol. 329, 111050
Purity of street-level cocaine across Denmark from 2006 to 2019: Analysis of seized cocaine
- 1 December 2021
- Published by Elsevier in Forensic Science International
- Vol. 329, 111050
Open AccessPurity of street-level cocaine across Denmark from 2006 to 2019: Analysis of seized cocaine
- Open Access
- 1 June 2016
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Forensic Science
- Vol. 22 (1) , 6-10
A case story, involving the use of maltitol, a sugar alcohol, as a cutting agent in amphetamine and cocaine powders
In a criminal case involving cutting and resale of amphetamine and cocaine in the Copenhagen area of Denmark, maltitol was used as a cutting agent. The analysis of maltitol in seizures of pure diluents as well as in amphetamine and cocaine powders was carried out using reversed-phase high performance liquid chromatography (HPLC) with high-resolution (HR) mass spectrometric detection. Maltitol was identified in four out of nine amphetamine samples and in five out of six cocaine samples from the case in question. The use of maltitol as a cutting agent was considered by the police as a specific marker of the particular criminal group under investigation. To support or reject this hypothesis, cocaine and amphetamine samples from a four month period after the involved persons had been arrested were evaluated, also as part of the police investigation. None of these samples contained maltitol. The work described covers the part of the case involving the department of forensic chemistry, and not the whole police investigation, but everything was done within the frames given by the police. To the best of our knowledge, this is the first report of a disaccharide polyol being used as a cutting agent for illicit drugs.
- 1 June 2016
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Forensic Science
- Vol. 22 (1) , 6-10
Open AccessA case story, involving the use of maltitol, a sugar alcohol, as a cutting agent in amphetamine and cocaine powders
In a criminal case involving cutting and resale of amphetamine and cocaine in the Copenhagen area of Denmark, maltitol was used as a cutting agent. The analysis of maltitol in seizures of pure diluents as well as in amphetamine and cocaine powders was carried out using reversed-phase high performance liquid chromatography (HPLC) with high-resolution (HR) mass spectrometric detection. Maltitol was identified in four out of nine amphetamine samples and in five out of six cocaine samples from the case in question. The use of maltitol as a cutting agent was considered by the police as a specific marker of the particular criminal group under investigation. To support or reject this hypothesis, cocaine and amphetamine samples from a four month period after the involved persons had been arrested were evaluated, also as part of the police investigation. None of these samples contained maltitol. The work described covers the part of the case involving the department of forensic chemistry, and not the whole police investigation, but everything was done within the frames given by the police. To the best of our knowledge, this is the first report of a disaccharide polyol being used as a cutting agent for illicit drugs.
- Open Access
- 1 December 2014
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Forensic Science
- Vol. 20 (2) , 42-49
Identification of peptide and protein doping related drug compounds confiscated in Denmark between 2007-2013
We present an overview of protein and peptide compounds confiscated in Denmark from late 2007 till late 2013 together with a description of a newly developed HRAM-LC-MS method used for identification. As examples of identification, we present data for the peptides AOD-9604, [D-Ala2, Gln8, Ala15, Leu27]sermorelin and the protein follistatin. It was found that a method with minimum sample preparation could be implemented for all of the confiscated peptides and the protein somatropin. However, for the protein follistatin it was necessary to include trypsin digestion in the sample preparation, which considerably increases the overall analysis time.
- 1 December 2014
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Forensic Science
- Vol. 20 (2) , 42-49
Open AccessIdentification of peptide and protein doping related drug compounds confiscated in Denmark between 2007-2013
We present an overview of protein and peptide compounds confiscated in Denmark from late 2007 till late 2013 together with a description of a newly developed HRAM-LC-MS method used for identification. As examples of identification, we present data for the peptides AOD-9604, [D-Ala2, Gln8, Ala15, Leu27]sermorelin and the protein follistatin. It was found that a method with minimum sample preparation could be implemented for all of the confiscated peptides and the protein somatropin. However, for the protein follistatin it was necessary to include trypsin digestion in the sample preparation, which considerably increases the overall analysis time.
- 9 May 2012
- Published by Wiley in Drug Testing and Analysis
- Vol. 5 (6) , 430-438
In vitro metabolism studies on mephedrone and analysis of forensic cases
The stimulant designer drug mephedrone is a derivative of cathinone – a monoamine alkaloid found in khat – and its effect resembles that of 3,4‐Methylenedioxymethamphetamine (MDMA). Abuse of mephedrone has been documented since 2007; it was originally a ‘legal high’ drug, but it has now been banned in most Western countries.Using cDNA‐expressed CYP enzymes and human liver microsomal preparations, we found that cytochrome P450 2D6 (CYP2D6) was the main responsible enzyme for the in vitro Phase I metabolism of mephedrone, with some minor contribution from other NAPDH‐dependent enzymes.Hydroxytolyl‐mephedrone and nor‐mephedrone were formed in vitro, and the former was purified and identified by nuclear magnetic resonance (NMR). In four forensic traffic cases where mephedrone was detected, we identified hydroxytolyl‐mephedrone and nor‐mephedrone again; as well as 4‐carboxy‐dihydro‐mephedrone, which has been previously described; and two new metabolites: dihydro‐mephedrone and 4‐carboxy‐mephedrone. Fragmentation patterns for all detected compounds were determined by a UPLC‐QTOF/MSE system, and a fragmentation pathway via a conjugated indole structure was proposed for most of the metabolites. Blood concentrations in the forensic traffic cases ranged from 1 to 51 µg/kg for mephedrone, and from not detected to 9 µg/kg for hydroxytolyl‐mephedrone. In one case, urine concentrations were also determined to be 700 µg/kg for mephedrone and 190 µg/kg for hydroxytolyl‐mephedrone. All compounds were detected or quantified with an ultra performance liquid chromatography‐tandem mass spectrometry (UPLC‐MS/MS) system and an ultra performance liquid chromatography‐time of flight/mass spectrometry (UPLC‐TOF/MS) system. Copyright © 2012 John Wiley & Sons, Ltd.
- 9 May 2012
- Published by Wiley in Drug Testing and Analysis
- Vol. 5 (6) , 430-438
In vitro metabolism studies on mephedrone and analysis of forensic cases
The stimulant designer drug mephedrone is a derivative of cathinone – a monoamine alkaloid found in khat – and its effect resembles that of 3,4‐Methylenedioxymethamphetamine (MDMA). Abuse of mephedrone has been documented since 2007; it was originally a ‘legal high’ drug, but it has now been banned in most Western countries.Using cDNA‐expressed CYP enzymes and human liver microsomal preparations, we found that cytochrome P450 2D6 (CYP2D6) was the main responsible enzyme for the in vitro Phase I metabolism of mephedrone, with some minor contribution from other NAPDH‐dependent enzymes.Hydroxytolyl‐mephedrone and nor‐mephedrone were formed in vitro, and the former was purified and identified by nuclear magnetic resonance (NMR). In four forensic traffic cases where mephedrone was detected, we identified hydroxytolyl‐mephedrone and nor‐mephedrone again; as well as 4‐carboxy‐dihydro‐mephedrone, which has been previously described; and two new metabolites: dihydro‐mephedrone and 4‐carboxy‐mephedrone. Fragmentation patterns for all detected compounds were determined by a UPLC‐QTOF/MSE system, and a fragmentation pathway via a conjugated indole structure was proposed for most of the metabolites. Blood concentrations in the forensic traffic cases ranged from 1 to 51 µg/kg for mephedrone, and from not detected to 9 µg/kg for hydroxytolyl‐mephedrone. In one case, urine concentrations were also determined to be 700 µg/kg for mephedrone and 190 µg/kg for hydroxytolyl‐mephedrone. All compounds were detected or quantified with an ultra performance liquid chromatography‐tandem mass spectrometry (UPLC‐MS/MS) system and an ultra performance liquid chromatography‐time of flight/mass spectrometry (UPLC‐TOF/MS) system. Copyright © 2012 John Wiley & Sons, Ltd.
- 18 November 2011
- Published by Wiley in Drug Testing and Analysis
- Vol. 4 (5) , 342-354
Identification of ten new designer drugs by GC‐MS, UPLC‐QTOF‐MS, and NMR as part of a police investigation of a Danish Internet company
The ability of forensic laboratories to detect and identify unknown compounds is highly important since new, non‐controlled designer drugs are appearing on the market with increasing frequency. In this study, the combined use of gas chromatography‐mass spectrometry (GC‐MS) and ultra performance liquid chromatography‐quadrupole time of flight‐mass spectrometry (UPLC‐QTOF‐MS) was used for screening of new unknowns. In one large seizure from a Danish Internet company, ten different drugs were identified. Several of the compounds were seized for the first time in Denmark. The GC‐MS and UPLC‐QTOF‐MS analyses were supplemented by nuclear magnetic resonance (NMR) spectra for the structural elucidation of p‐fluoroamphetamine, mephedrone (4‐methylmethcathinone), flephedrone (4‐fluoromethcathinone), PPP (α‐pyrrolidinopropiophenone), MDPV (3,4‐methylenedioxypyrovalerone), Bk‐MBDB (2‐methylamino‐1‐(3,4‐methylenedioxyphenyl)butan‐1‐one), pFBT (3‐(pfluorobenzoyl)‐tropane), and JWH‐073 (1‐butyl‐3‐(1‐naphthoyl)indol), whereas methylone (3,4‐methylenedioxymethcathinone) and N‐ethylcathinone matched electron impact‐mass spectrometry (EI‐MS) library spectra and therefore the screenings were considered sufficient.EI‐MS spectra and the proposed main fragmentation patterns are presented as well as QTOF‐MS exact masses and fragments and NMR chemical shifts. For the β‐ketophenylethylamines (mephedrone, flephedrone, PPP, MDPV, Bk‐MBDB, methylone, and N‐ethylcathinone) some general fragmentation patterns observed in the EI‐MS and QTOF‐MS spectra are further discussed and compared to other β‐ketophenylethylamines. Copyright © 2011 John Wiley & Sons, Ltd.
- 18 November 2011
- Published by Wiley in Drug Testing and Analysis
- Vol. 4 (5) , 342-354
Identification of ten new designer drugs by GC‐MS, UPLC‐QTOF‐MS, and NMR as part of a police investigation of a Danish Internet company
The ability of forensic laboratories to detect and identify unknown compounds is highly important since new, non‐controlled designer drugs are appearing on the market with increasing frequency. In this study, the combined use of gas chromatography‐mass spectrometry (GC‐MS) and ultra performance liquid chromatography‐quadrupole time of flight‐mass spectrometry (UPLC‐QTOF‐MS) was used for screening of new unknowns. In one large seizure from a Danish Internet company, ten different drugs were identified. Several of the compounds were seized for the first time in Denmark. The GC‐MS and UPLC‐QTOF‐MS analyses were supplemented by nuclear magnetic resonance (NMR) spectra for the structural elucidation of p‐fluoroamphetamine, mephedrone (4‐methylmethcathinone), flephedrone (4‐fluoromethcathinone), PPP (α‐pyrrolidinopropiophenone), MDPV (3,4‐methylenedioxypyrovalerone), Bk‐MBDB (2‐methylamino‐1‐(3,4‐methylenedioxyphenyl)butan‐1‐one), pFBT (3‐(pfluorobenzoyl)‐tropane), and JWH‐073 (1‐butyl‐3‐(1‐naphthoyl)indol), whereas methylone (3,4‐methylenedioxymethcathinone) and N‐ethylcathinone matched electron impact‐mass spectrometry (EI‐MS) library spectra and therefore the screenings were considered sufficient.EI‐MS spectra and the proposed main fragmentation patterns are presented as well as QTOF‐MS exact masses and fragments and NMR chemical shifts. For the β‐ketophenylethylamines (mephedrone, flephedrone, PPP, MDPV, Bk‐MBDB, methylone, and N‐ethylcathinone) some general fragmentation patterns observed in the EI‐MS and QTOF‐MS spectra are further discussed and compared to other β‐ketophenylethylamines. Copyright © 2011 John Wiley & Sons, Ltd.